TL;DR: Nuntius Therapeutics is a Y Combinator Winter 2021 startup Cell-specific genetic medicines, currently active with a team of 2.
Cell-specific genetic medicines
Last verified:
Built by LemStudio
Yes. Nuntius Therapeutics was funded by Y Combinator in the Winter 2021 batch. Cell-specific genetic medicines
Cell-specific genetic medicines
Nuntius Therapeutics was part of Y Combinator's Winter 2021 batch.
Nuntius Therapeutics has a team of 2 people according to Y Combinator's directory.
Nuntius Therapeutics is currently listed as Active with a team of 2 in Y Combinator's directory.
Loading interactive view…